LLY

1,062.5

+2.21%↑

JNJ

208.38

-0.82%↓

ABBV

224.35

-0.35%↓

UNH

327.5

-1.41%↓

AZN

90.72

+0.41%↑

LLY

1,062.5

+2.21%↑

JNJ

208.38

-0.82%↓

ABBV

224.35

-0.35%↓

UNH

327.5

-1.41%↓

AZN

90.72

+0.41%↑

LLY

1,062.5

+2.21%↑

JNJ

208.38

-0.82%↓

ABBV

224.35

-0.35%↓

UNH

327.5

-1.41%↓

AZN

90.72

+0.41%↑

LLY

1,062.5

+2.21%↑

JNJ

208.38

-0.82%↓

ABBV

224.35

-0.35%↓

UNH

327.5

-1.41%↓

AZN

90.72

+0.41%↑

LLY

1,062.5

+2.21%↑

JNJ

208.38

-0.82%↓

ABBV

224.35

-0.35%↓

UNH

327.5

-1.41%↓

AZN

90.72

+0.41%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

SectorHealthcare

37.58 -3.74

Buy Sell

Overview

Share price change

24h

Current

Min

37.06

Max

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	12.278 76.798
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+18.62% upside

Market Stats
By TradingEconomics
Market Cap	554M 2.2B
Previous open	41.32
Previous close	37.58

News Sentiment

By Acuity

21%

79%

46 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 gru 2025, 23:50 UTC

Hot Stocks

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 gru 2025, 23:20 UTC

Earnings

Correction to Micron Logs Sales Jump Article

17 gru 2025, 23:07 UTC

Earnings

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 gru 2025, 21:37 UTC

Earnings

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 gru 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 gru 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 gru 2025, 23:06 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 gru 2025, 23:05 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 gru 2025, 23:04 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 gru 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 gru 2025, 23:02 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 gru 2025, 22:59 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 gru 2025, 22:57 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 gru 2025, 22:56 UTC

Acquisitions, Mergers, Takeovers

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 gru 2025, 22:55 UTC

Acquisitions, Mergers, Takeovers

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 gru 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 gru 2025, 21:58 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

17 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 gru 2025, 21:46 UTC

Earnings

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 gru 2025, 21:20 UTC

Earnings

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:10 UTC

Earnings

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 gru 2025, 21:05 UTC

Earnings

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 gru 2025, 21:04 UTC

Earnings

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 gru 2025, 21:04 UTC

Earnings

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 gru 2025, 21:03 UTC

Earnings

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 gru 2025, 21:02 UTC

Earnings

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 gru 2025, 21:01 UTC

Earnings

Micron Technology 1Q Rev $13.64B >MU

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

18.62% upside

12 Months Forecast

Average 46 USD 18.62%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

46 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.